Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Non-interventional Study on the Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia (MILOS)

Next Previous
X
Search
Trial Profile

Non-interventional Study on the Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia (MILOS)

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bempedoic acid (Primary) ; Bempedoic acid/ezetimibe (Primary)
  • Indications Dyslipidaemias; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms MILOS
  • Sponsors Daiichi Sankyo Europe

    • Most Recent Events

    • 28 Aug 2023 Results (n=992) assessing evaluate the effectiveness and safety of BA and its FDC in routine clinical practice in Germany presented at the ESC Congress 2023 - Annual Congress of the European Society of Cardiology
    • 27 Jan 2023 Planned End Date changed from 1 Sep 2024 to 1 Sep 2025.
    • 27 Jan 2023 Planned primary completion date changed from 1 Sep 2024 to 1 Sep 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top